Eran Broshy Theravance Biopharma, Inc. (TBPH) insider trading activity

Eran Broshy is of Theravance Biopharma, Inc.. Currently has a direct ownership of 44,703 shares of TBPH, which is worth approximately $777,385. The most recent transaction as insider was on Nov 26, 2025, when has been sold 29,501 shares (Ordinary Shares) at a price of $20.0 per share, resulting in proceeds of $590,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.7K

50.99% 3M change

44.51% 12M change

Total Value Held $777,385

ERAN BROSHY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 26 2025	SELL Open market or private sale	$590,020 $20.0 p/Share	29,501 Reduced 39.76%	44,703 Ordinary Shares
Nov 11 2025	SELL Open market or private sale	$1,062,000 $18.0 p/Share	59,000 Reduced 56.08%	46,204 Ordinary Shares
May 19 2025	BUY Grant, award, or other acquisition	-	10,649 Added 10.46%	91,204 Ordinary Shares
May 08 2024	BUY Grant, award, or other acquisition	-	10,537 Added 11.57%	80,555 Ordinary Shares
May 02 2023	BUY Grant, award, or other acquisition	-	9,132 Added 11.54%	70,018 Ordinary Shares
Apr 26 2022	BUY Grant, award, or other acquisition	-	9,852 Added 13.93%	60,886 Ordinary Shares
Apr 27 2021	BUY Grant, award, or other acquisition	-	9,828 Added 16.15%	51,034 Ordinary Shares

Also insider at

CERT

Certara, Inc. Healthcare

Eran Broshy

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account